IndiaCatalog.com
India News
Search Web Directory
News Home
Cipla arm InvaGen Pharma gets USFDA nod for neuropathic pain management drug
Posted on 22nd July 2019
Drug major Cipla Monday said its subsidiary InvaGen Pharmaceuticals has received final approval from the US health regulator for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses.

InvaGen has received approval from the the United States Food and Drug Administration (USFDA) for the drug in the strengths of 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg, Cipla said in a regulatory filing.

Cipla said the approved product is a generic therapeutic equivalent version of Pfizer’s Lyrica.

Pregabalin capsules are indicated for management of neuropathic pain associated with diabetic peripheral neuropathy, management of postherpetic neuralgia, adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, management of fibromyalgia and management of neuropathic pain associated with spinal cord injury.

Quoting IQVIA data, Cipla said Lyrica had an estimated market size of USD 5.4 billion for 12 months ending March 2019. The product is available for shipping immediately, the company added. Shares of Cipla were trading 0.18 per cent lower at Rs 535.90 apiece on the BSE.

Related Companies: Cipla Limited - Mumbai.   

Other Latest News
EPFO to cover 400,000 employees in J&K: 5 Key benefits for workers of organized sector
Posted on 19th October 2019
NEW DELHI : Retirement fund manager Employees Provident Fund Organization (EPFO) will cover 400,000 organized sector employees in Jammu and Kashmir and Ladakh, effective 31 October, making them eligible for a series of social security benefits ranging from family and disability pension to higher life insurance, among others. It shall also reduce the employee cost for companies to some extent.

Strategic sale buzz: BHEL gains 27.5% in intra-day trade
Posted on 19th October 2019
Strategic sale buzz fuelled a sharp 27.5% rise on Friday in the share price of Bharat Heavy Electricals (BHEL) during the intra-day trade on BSE. The stock rose to Rs 56.80 on Friday, before closing at Rs 54.45, 22.2% higher than the previous day’s close. It had hit a 52-week low of Rs 41.35 on Wednesday, as the company battled through tough times stemming from execution delays and low order inflows.

ITC to develop value chain for chilli growers in Andhra Pradesh
Posted on 19th October 2019
The Agri Business Division of ITC Ltd has joined hands with the Andhra Pradesh government for improving farm value chain for chillies under public-private partnership mode covering Krishna, Guntur, Prakasam and Kurnool districts of the southern state. The collaboration will focus on developing an integrated agri extension platform for chilli value chain development, covering 10,000 acre in the first phase and another 100,000 acre in the near future.

IMF says corporate tax cut has a positive impact on investment in India
Posted on 19th October 2019
The International Monetary Fund (IMF) on Friday supported India's decision to cut corporate income tax, saying that it has a positive impact on investment.

It, however, advised India to address the continued fiscal consolidation and secure long-term stability of the fiscal conditions.


Sebi tightens norms to deal with abrupt resignations of auditors
Posted on 19th October 2019
The Securities and Exchange Board of India (Sebi) on Friday tightened the rules around resignations of auditors from listed companies.

The market regulator has said that an auditor will have to provide review — limited or complete audit report — for the quarter during which it resigns. For instance, if the auditor decides to resign in August 2019, it will have to issue the review for the quarter ended September 30, 2019.


» Post a FREE Classified Advertisement
Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.
Jobs in India India Real Estate Automobiles Matrimonials Beauty & Fitness

Add a comment for Cipla arm InvaGen Pharma gets USFDA nod for neuropathic pain management drug
Please only use this form to enter comments on the above company. All comments are reviewed before they are displayed on the web site. Not all comments may be displayed. Check back with us to see if your comments have been displayed.
If you want us to email the comments posted by users, please Subscribe by email
Name*
Comments*
Security Code*
 

Be the first person to write a business review for Cipla arm InvaGen Pharma gets USFDA nod for neuropathic pain management drug

Most Read News

Daimler recalls hundreds of thousands of Mercedes-Benz diesel vehicles

SBI re-enters list of India's top-10 most valued firms

Mary Kom signs off with bronze in World Boxing Championships

Infosys meets Street expectations; raises revenue guidance

Air India Assets Holding raises another Rs 7,985 cr

More India News

  India Web Directory
Business Profiles
Automotive Directory
IT/ITES/BPO Directory
Hotel Directory
Health Directory
Business Directory
Gems & Jewellery
Education Directory
Real Estate Directory
Agriculture Directory
Logistics Directory
Yellow Pages
NRI Guide
Photo Galleries
Global Web Directory
*** FREE India Classifieds
Order Premium Listings
Submit a Site
Business Reviews
Home
About us
Link to us
Advertise
Contact us
Google Search Keywords: India Catalog, IndiaCatalog, India Web Directory
    © 1999 - 2019 IndiaCatalog.com
    All Rights Reserved
Privacy Statement